ASTRA ZENECA TO CLOSE BANGALORE R & D

AstraZeneca is to close its research and development unit in Bangalore, India, making more than 150 jobs redundant.

The move, as part of an ongoing global restructuring exercise, will also shut down its early stage research on tropical diseases tuberculosis and malaria.

The existing research will be moved to its UK facility at Macclesfield or outsourced to a third party.

Sudhir Nambiar, site head and vice president of pharmaceutical development at the Bangalore unit, said in a statement “We realise this is difficult news for our research colleagues in Bangalore and our priority is to support them over the coming months.